Editorial & Content Review Policy
Every monograph carries an explicit clinical review badge (28 Verified Baseline, 241 Handbook-Source Awaiting Clinical Review, 1 Specialist PK Review Pending).
Open Interactive Platform & Full Workspace →Editorial Governance, Compendial Verification & Review Standards
THE INDIAN PHARMACIST maintains a strict, multi-source pharmaceutical verification workflow overseen by founder and lead author Tejas Chandrakant Nartam (Registered Allopathic Pharmacist, CGHS Nagpur). Every monograph, calculator algorithm, and statutory note is authored to serve Indian pharmacy students, educators, and practicing hospital/community pharmacists with accurate, non-promotional reference material.
1. Five-Tier Authoritative Source Hierarchy
Before publication or release upgrade, every clinical claim, pharmacokinetic parameter, regulatory schedule, and dosage range is cross-referenced against primary compendia and statutory authorities:
- Indian Statutory & Compendial Standards: Indian Pharmacopoeia (IP 2022) & National Formulary of India (NFI), Central Drugs Standard Control Organization (CDSCO) approved drug lists, MoHFW National List of Essential Medicines (NLEM 2022), and the Drugs and Cosmetics Act, 1940 & Rules, 1945 (Pharmacy Law Hub).
- National Clinical & Public Health Guidelines: Indian Council of Medical Research (ICMR) Antimicrobial Stewardship and Standard Treatment Workflows, National Tuberculosis Elimination Programme (NTEP), NACO Antiretroviral Therapy guidelines, and NVBDCP vector-borne disease protocols.
- International Peer-Reviewed & Regulatory Compendia: NCBI Bookshelf / StatPearls, US FDA DailyMed structured product labels, WHO Model List of Essential Medicines, and KDIGO/GOLD/ESC/ADA clinical consensus guidelines.
- Deterministic Calculator Validation: All 32 Pharmacy Calculators are verified against standard pharmaceutical calculation textbooks (Ansel's Pharmaceutical Calculations, Remington) with explicit unit-conversion bounds and dimensional analysis.
- Jurisdictional Separation: Whenever a drug is approved internationally (FDA/EMA) or available via named-patient import while holding specific Indian Schedule H/H1/X or NLEM status, our monographs explicitly distinguish Indian regulatory status from global reference labels.
2. Independence, Non-Endorsement & Correction Protocol
Editorial content is written independently without sponsorship from pharmaceutical manufacturers. Brand names listed in the 744-Profile Reference Library and 679-Drug Comparison Centre represent verified Indian market examples for educational identification only. Substantive updates, errata corrections, and compendial revisions can be submitted via our Contact & Errata Page.
Statutory, Regulatory & Compendial Reference Matrix for Indian Pharmacy Practice
Every institutional policy, examination resource, and clinical reference module on THE INDIAN PHARMACIST adheres to the primary statutory frameworks governing pharmaceutical education, drug regulation, pharmacovigilance, and essential medicine access in India:
| Statutory / Compendial Authority | Governing Legislation / Standard | Core Scope in Pharmacy Practice & Education | Platform Reference Module |
|---|---|---|---|
| Central Drugs Standard Control Organization (CDSCO) | Drugs and Cosmetics Act, 1940 & Rules, 1945; New Drugs and Clinical Trials (NDCT) Rules, 2019 | New drug approval, import registration, Schedule C/C1, G, H, H1, X, and Revised Schedule M (GMP) enforcement across India. | Indian Pharmacy Law Hub (17 Statutes) |
| Indian Pharmacopoeia Commission (IPC), Ghaziabad | Indian Pharmacopoeia (IP 2022), National Formulary of India (NFI), & PvPI | Official compendial identity, purity, assay, dissolution, sterility standards, and national adverse drug reaction (ADR) reporting. | 744 Verified Medicine & Reference Profiles |
| Ministry of Health & Family Welfare (MoHFW) | National List of Essential Medicines (NLEM 2022) & National Health Programmes | Selection of 384 essential medicines across 27 therapeutic categories stratified by Primary (P), Secondary (S), and Tertiary (T) care levels. | 679-Drug Side-by-Side Comparison Centre |
| Pharmacy Council of India (PCI) | Pharmacy Act, 1948; Education Regulations (ER-2020); Pharmacy Practice Regulations, 2015 | Registration of pharmacists, D.Pharm/B.Pharm/Pharm.D curriculum standards, Good Pharmacy Practice (GPP), and patient counselling ethics. | 63 Academic Curriculum Chapters & 80 Flashcards |